查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1726216

人類乳突病毒檢測市場規模、佔有率、趨勢分析報告：按應用、產品、技術、最終用途、地區和細分市場預測，2025 年至 2030 年

Human Papilloma Virus Testing Market Size, Share, & Trends Analysis Report By Application (Cervical Cancer Screening, Vaginal Cancer Screening), By Product, By Technology, By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10個工作天內

價格

市場規模和趨勢

2024 年全球人類乳突病毒 (HPV) 檢測市場規模價值 17.6 億美元，預計 2025 年至 2030 年期間的複合年成長率為 13.6%，這得益於人們對子宮頸癌和咽喉癌等 HPV 相關癌症的認知不斷提高。

教育工作和公共衛生宣傳活動鼓勵定期檢測，從而提高篩檢率。

家用檢測套組的普及進一步推動了市場擴張。這些套件為個人提供了一種方便、個人化且易於獲取的 HPV 檢測方式，使他們能夠更積極地管理自己的健康。人們對家庭檢測的認知不斷提高以及家庭檢測的普及極大地推動了市場需求。

預防性醫療保健需求的不斷成長預計將推動 HPV 檢測行業的發展，越來越多的人尋求早期檢測以避免 HPV 相關癌症。這種向積極主動的健康實踐的轉變鼓勵定期進行 HPV篩檢，特別是對於 30 歲以上的女性。 PCR 和次世代定序等檢測方法的技術進步使得 HPV 檢測更加準確和有效率。這些技術創新使檢測更加便利、可靠、經濟高效，有助於擴大市場，改善患者的整體體驗，並鼓勵更廣泛地採用 HPV 檢測解決方案。

目錄

第1章調查方法與範圍

第2章執行摘要

3. 人類乳突病毒 (HPV) 檢測市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/支持市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 人類乳突病毒（HPV）檢測市場分析工具
    • 產業分析—波特五力分析
    • PESTLE分析

第4章 人類乳突病毒 (HPV) 檢測市場：按應用的估計和趨勢分析

  • 應用程式細分儀表板
  • 人類乳突病毒（HPV）檢測市場：應用趨勢分析
  • 2018-2030年全球人類乳突病毒（HPV）檢測市場規模及應用趨勢分析
  • 子宮頸癌篩檢
  • 陰道癌篩檢

第5章 人類乳突病毒 (HPV) 檢測市場：產品、估值和趨勢分析

  • 產品細分儀表板
  • 人類乳突病毒（HPV）檢測市場：產品差異分析
  • 2018-2030年全球人類乳突病毒（HPV）檢測市場規模及產品趨勢分析
  • 裝置
  • 耗材
  • 服務

6. 人類乳突病毒（HPV）檢測市場（依技術、估值和趨勢分析）

  • 技術細分儀表板
  • 人類乳突病毒（HPV）檢測市場：技術變革分析
  • 2018-2030年全球人類乳突病毒（HPV）檢測市場規模及趨勢分析（依技術）
  • PCR
  • 免疫診斷
  • 其他

7. 人類乳突病毒（HPV）檢測市場最終用途、估值及趨勢分析

  • 最終用途細分儀表板
  • 人類乳突病毒 (HPV) 檢測市場：最終用途變異分析
  • 2018-2030年全球人類乳突病毒（HPV）檢測市場規模及趨勢分析（依最終用途）
  • 醫院和診所
  • 實驗室
  • 其他

8. 人類乳突病毒（HPV）檢測市場：區域、估值和趨勢分析

  • 區域市場儀表板
  • 2024 年及 2030 年區域市場佔有率分析
  • 區域 HPV 檢測市場：關鍵要點
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭態勢

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商格局
    • 2024年主要企業熱圖分析
  • 公司簡介
    • Abbott
    • Biomedical Diagnostics
    • bioMerieux
    • CanAg Diagnostics（Beijing）Co., Ltd.
    • Cemines
    • Bio-Rad Laboratories, Inc.
    • Epigenomics AG
    • Fujirebio
    • Guided Therapeutics, Inc.
    • Oncolab
    • Hologic, Inc.
    • Qiagen
    • Radiant Pharmaceuticals Limited
    • F. Hoffmann-La Roche Ltd
    • Siemens Healthineers AG
Product Code: GVR-4-68040-549-5

Market Size & Trends:

The global human papilloma virus testing market size was valued at USD 1.76 billion in 2024 and is expected to grow at a CAGR of 13.6% from 2025 to 2030, attributed to increasing awareness of HPV-related cancers, such as cervical and throat cancers. Educational initiatives and public health campaigns encourage people to get tested regularly, leading to higher screening rates.

The adoption of at-home testing kits is further driving market expansion. These kits provide a convenient, private, and accessible method for individuals to test for HPV, empowering users to manage their health more proactively. The combination of heightened awareness and the availability of at-home testing is significantly boosting market demand.

Rising demand for preventive healthcare is projected to fuel the growth of the HPV testing industry, with more individuals seeking early detection to avoid HPV-related cancers. This shift toward proactive health measures encourages routine HPV screenings, especially for women over 30. Technological advancements in testing methods, including PCR-based and next-generation sequencing, are further enhancing the accuracy and efficiency of HPV tests. These innovations make testing more accessible, reliable, and cost-effective, thus driving market expansion by improving the overall patient experience and encouraging broader adoption of HPV testing solutions.

Global Human Papilloma Virus Testing Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global human papilloma virus (HPV) testing market report on the basis of application, product, technology, end use, and region:

  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Cervical Cancer Screening
  • Vaginal Cancer Screening
  • Product Outlook (Revenue, USD Million, 2018 - 2030)
  • Instruments
  • Consumables
  • Services
  • Technology Outlook (Revenue, USD Million, 2018 - 2030)
  • PCR
  • Immunodiagnostics
  • Others
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals & Clinics
  • Laboratories
  • Others
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Application
    • 1.2.2. Product
    • 1.2.3. Technology
    • 1.2.4. End Use
    • 1.2.5. Regional Scope
    • 1.2.6. Estimates and Forecasts Timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
    • 1.4.5. Details of Primary Research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Application Outlook
    • 2.2.2. Product Outlook
    • 2.2.3. Technology Outlook
    • 2.2.4. End Use Outlook
    • 2.2.5. Regional Outlook
  • 2.3. Competitive Scenario

Chapter 3. Human Papilloma Virus (HPV) Testing Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Human Papilloma Virus (HPV) Testing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrant
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
      • 3.3.2.1. Political Landscape
      • 3.3.2.2. Technological Landscape
      • 3.3.2.3. Economic Landscape

Chapter 4. Human Papilloma Virus (HPV) Testing Market: Application Estimates & Trend Analysis

  • 4.1. Application Segment Dashboard
  • 4.2. Human Papilloma Virus (HPV) Testing Market: Application Movement Analysis
  • 4.3. Global Human Papilloma Virus (HPV) Testing Market Size & Trend Analysis, By Application, 2018 to 2030 (USD Million)
  • 4.4. Cervical Cancer Screening
    • 4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.5. Vaginal Cancer Screening
    • 4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 5. Human Papilloma Virus (HPV) Testing Market: Product Estimates & Trend Analysis

  • 5.1. Product Segment Dashboard
  • 5.2. Human Papilloma Virus (HPV) Testing Market: Product Movement Analysis
  • 5.3. Global Human Papilloma Virus (HPV) Testing Market Size & Trend Analysis, By Product, 2018 to 2030 (USD Million)
  • 5.4. Instruments
    • 5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.5. Consumables
    • 5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.6. Services
    • 5.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 6. Human Papilloma Virus (HPV) Testing Market: Technology Estimates & Trend Analysis

  • 6.1. Technology Segment Dashboard
  • 6.2. Human Papilloma Virus (HPV) Testing Market: Technology Movement Analysis
  • 6.3. Global Human Papilloma Virus (HPV) Testing Market Size & Trend Analysis, By Technology, 2018 to 2030 (USD Million)
  • 6.4. PCR
    • 6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.5. Immunodiagnostics
    • 6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 7. Human Papilloma Virus (HPV) Testing Market: End Use Estimates & Trend Analysis

  • 7.1. End Use Segment Dashboard
  • 7.2. Human Papilloma Virus (HPV) Testing Market: End Use Movement Analysis
  • 7.3. Global Human Papilloma Virus (HPV) Testing Market Size & Trend Analysis, By End Use, 2018 to 2030 (USD Million)
  • 7.4. Hospitals & Clinics
    • 7.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.5. Laboratories
    • 7.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.6. Others
    • 7.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 8. Human Papilloma Virus (HPV) Testing Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Dashboard
  • 8.2. Regional Market Share Analysis, 2024 & 2030
  • 8.3. Human Papilloma Virus (HPV) Testing Market by Region: Key Takeaways
  • 8.4. North America
    • 8.4.1. U.S.
      • 8.4.1.1. Key Country Dynamics
      • 8.4.1.2. Regulatory Framework/ Reimbursement Structure
      • 8.4.1.3. Competitive Scenario
      • 8.4.1.4. U.S. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.4.2. Canada
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Regulatory Framework/ Reimbursement Structure
      • 8.4.2.3. Competitive Scenario
      • 8.4.2.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.4.3. Mexico
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Regulatory Framework/ Reimbursement Structure
      • 8.4.3.3. Competitive Scenario
      • 8.4.3.4. Mexico Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.5. Europe
    • 8.5.1. Germany
      • 8.5.1.1. Key Country Dynamics
      • 8.5.1.2. Regulatory Framework/ Reimbursement Structure
      • 8.5.1.3. Competitive Scenario
      • 8.5.1.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.5.2. U.K.
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Regulatory Framework/ Reimbursement Structure
      • 8.5.2.3. Competitive Scenario
      • 8.5.2.4. U.K. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.5.3. France
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Regulatory Framework/ Reimbursement Structure
      • 8.5.3.3. Competitive Scenario
      • 8.5.3.4. France Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.5.4. Italy
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Regulatory Framework/ Reimbursement Structure
      • 8.5.4.3. Competitive Scenario
      • 8.5.4.4. Italy Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.5.5. Spain
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Regulatory Framework/ Reimbursement Structure
      • 8.5.5.3. Competitive Scenario
      • 8.5.5.4. Spain Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.5.6. Denmark
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Regulatory Framework/ Reimbursement Structure
      • 8.5.6.3. Competitive Scenario
      • 8.5.6.4. Denmark Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.5.7. Sweden
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Regulatory Framework/ Reimbursement Structure
      • 8.5.7.3. Competitive Scenario
      • 8.5.7.4. Sweden Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.5.8. Norway
      • 8.5.8.1. Key Country Dynamics
      • 8.5.8.2. Regulatory Framework/ Reimbursement Structure
      • 8.5.8.3. Competitive Scenario
      • 8.5.8.4. Norway Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Japan
      • 8.6.1.1. Key Country Dynamics
      • 8.6.1.2. Regulatory Framework/ Reimbursement Structure
      • 8.6.1.3. Competitive Scenario
      • 8.6.1.4. Japan Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.6.2. China
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Regulatory Framework/ Reimbursement Structure
      • 8.6.2.3. Competitive Scenario
      • 8.6.2.4. China Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.6.3. India
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Regulatory Framework/ Reimbursement Structure
      • 8.6.3.3. Competitive Scenario
      • 8.6.3.4. India Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.6.4. South Korea
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Regulatory Framework/ Reimbursement Structure
      • 8.6.4.3. Competitive Scenario
      • 8.6.4.4. South Korea Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.6.5. Australia
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Regulatory Framework/ Reimbursement Structure
      • 8.6.5.3. Competitive Scenario
      • 8.6.5.4. Australia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.6.6. Thailand
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Regulatory Framework/ Reimbursement Structure
      • 8.6.6.3. Competitive Scenario
      • 8.6.6.4. Thailand Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Latin America Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Regulatory Framework/ Reimbursement Structure
      • 8.7.2.3. Competitive Scenario
      • 8.7.2.4. Brazil Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.7.3. Argentina
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Regulatory Framework/ Reimbursement Structure
      • 8.7.3.3. Competitive Scenario
      • 8.7.3.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.8. Middle East and Africa
    • 8.8.1. Middle East and Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Regulatory Framework/ Reimbursement Structure
      • 8.8.2.3. Competitive Scenario
      • 8.8.2.4. South Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Regulatory Framework/ Reimbursement Structure
      • 8.8.3.3. Competitive Scenario
      • 8.8.3.4. Saudi Arabia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.8.4. UAE
      • 8.8.4.1. Key Country Dynamics
      • 8.8.4.2. Regulatory Framework/ Reimbursement Structure
      • 8.8.4.3. Competitive Scenario
      • 8.8.4.4. UAE Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key Country Dynamics
      • 8.8.5.2. Regulatory Framework/ Reimbursement Structure
      • 8.8.5.3. Competitive Scenario
      • 8.8.5.4. Kuwait Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/ Competition Categorization
  • 9.3. Vendor Landscape
    • 9.3.1. Key Company Heat Map Analysis, 2024
  • 9.4. Company Profiles
    • 9.4.1. Abbott
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Financial Performance
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Strategic Initiatives
    • 9.4.2. Biomedical Diagnostics
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Financial Performance
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Strategic Initiatives
    • 9.4.3. bioMerieux
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Financial Performance
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Strategic Initiatives
    • 9.4.4. CanAg Diagnostics (Beijing) Co., Ltd.
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Strategic Initiatives
    • 9.4.5. Cemines
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Financial Performance
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Strategic Initiatives
    • 9.4.6. Bio-Rad Laboratories, Inc.
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Financial Performance
      • 9.4.6.3. Product Benchmarking
      • 9.4.6.4. Strategic Initiatives
    • 9.4.7. Epigenomics AG
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Financial Performance
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Strategic Initiatives
    • 9.4.8. Fujirebio
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Financial Performance
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Strategic Initiatives
    • 9.4.9. Guided Therapeutics, Inc.
      • 9.4.9.1. Company Overview
      • 9.4.9.2. Financial Performance
      • 9.4.9.3. Product Benchmarking
      • 9.4.9.4. Strategic Initiatives
    • 9.4.10. Oncolab
      • 9.4.10.1. Company Overview
      • 9.4.10.2. Financial Performance
      • 9.4.10.3. Product Benchmarking
      • 9.4.10.4. Strategic Initiatives
    • 9.4.11. Hologic, Inc.
      • 9.4.11.1. Company Overview
      • 9.4.11.2. Financial Performance
      • 9.4.11.3. Product Benchmarking
      • 9.4.11.4. Strategic Initiatives
    • 9.4.12. Qiagen
      • 9.4.12.1. Company Overview
      • 9.4.12.2. Financial Performance
      • 9.4.12.3. Product Benchmarking
      • 9.4.12.4. Strategic Initiatives
    • 9.4.13. Radiant Pharmaceuticals Limited
      • 9.4.13.1. Company Overview
      • 9.4.13.2. Financial Performance
      • 9.4.13.3. Product Benchmarking
      • 9.4.13.4. Strategic Initiatives
    • 9.4.14. F. Hoffmann-La Roche Ltd
      • 9.4.14.1. Company Overview
      • 9.4.14.2. Financial Performance
      • 9.4.14.3. Product Benchmarking
      • 9.4.14.4. Strategic Initiatives
    • 9.4.15. Siemens Healthineers AG
      • 9.4.15.1. Company Overview
      • 9.4.15.2. Financial Performance
      • 9.4.15.3. Product Benchmarking
      • 9.4.15.4. Strategic Initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global Human Papilloma Virus (HPV) Testing Market, by Region, 2018 - 2030 (USD Million)
  • Table 4. Global Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 5. Global Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 6. Global Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 7. Global Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 8. North America Human Papilloma Virus (HPV) Testing Market, by Country, 2018 - 2030 (USD Million)
  • Table 9. North America Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 10. North America Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 11. North America Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 12. North America Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 13. U.S. Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 14. U.S. Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 15. U.S. Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 16. U.S. Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 17. Canada Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 18. Canada Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 19. Canada Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 20. Canada Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 21. Mexico Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 22. Mexico Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 23. Mexico Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 24. Mexico Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 25. Europe Human Papilloma Virus (HPV) Testing Market, by Country, 2018 - 2030 (USD Million)
  • Table 26. Europe Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 27. Europe Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 28. Europe Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 29. Europe Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 30. Germany Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 31. Germany Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 32. Germany Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 33. Germany Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 34. U.K. Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 35. U.K. Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 36. U.K. Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 37. U.K. Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 38. France Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 39. France Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 40. France Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 41. France Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 42. Italy Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 43. Italy Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 44. Italy Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 45. Italy Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 46. Spain Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 47. Spain Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 48. Spain Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 49. Spain Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 50. Denmark Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 51. Denmark Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 52. Denmark Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 53. Denmark Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 54. Sweden Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 55. Sweden Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 56. Sweden Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 57. Sweden Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 58. Norway Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 59. Norway Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 60. Norway Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 61. Norway Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 62. Asia Pacific Human Papilloma Virus (HPV) Testing Market, by Country, 2018 - 2030 (USD Million)
  • Table 63. Asia Pacific Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 64. Asia Pacific Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 65. Asia Pacific Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 66. Asia Pacific Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 67. Japan Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 68. Japan Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 69. Japan Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 70. Japan Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 71. China Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 72. China Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 73. China Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 74. China Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 75. India Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 76. India Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 77. India Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 78. India Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 79. South Korea Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 80. South Korea Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 81. South Korea Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 82. South Korea Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 83. Australia Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 84. Australia Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 85. Australia Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 86. Australia Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 87. Thailand Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 88. Thailand Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 89. Thailand Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 90. Thailand Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 91. Latin America Human Papilloma Virus (HPV) Testing Market, by Country, 2018 - 2030 (USD Million)
  • Table 92. Latin America Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 93. Latin America Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 94. Latin America Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 95. Latin America Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 96. Brazil Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 97. Brazil Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 98. Brazil Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 99. Brazil Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 100. Argentina Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 101. Argentina Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 102. Argentina Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 103. Argentina Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 104. Middle East & Africa Human Papilloma Virus (HPV) Testing Market, by Country, 2018 - 2030 (USD Million)
  • Table 105. Middle East & Africa Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 106. Middle East & Africa Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 107. Middle East & Africa Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 108. Middle East & Africa Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 109. South Africa Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 110. South Africa Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 111. South Africa Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 112. South Africa Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 113. Saudi Arabia Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 114. Saudi Arabia Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 115. Saudi Arabia Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 116. Saudi Arabia Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 117. UAE Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 118. UAE Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 119. UAE Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 120. UAE Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 121. Kuwait Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 122. Kuwait Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 123. Kuwait Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 124. Kuwait Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Techniques
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Primary Interviews
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value-Chain-Based Sizing & Forecasting
  • Fig. 7 QFD Modeling for Market Share Assessment
  • Fig. 8 Market Formulation & Validation
  • Fig. 9 Human Papilloma Virus (HPV) Testing Market: Market Outlook
  • Fig. 10 Human Papilloma Virus (HPV) Testing Competitive Insights
  • Fig. 11 Parent Market Outlook
  • Fig. 12 Related/Ancillary Market Outlook
  • Fig. 13 Penetration and Growth Prospect Mapping
  • Fig. 14 Industry Value Chain Analysis
  • Fig. 15 Human Papilloma Virus (HPV) Testing Market Driver Impact
  • Fig. 16 Human Papilloma Virus (HPV) Testing Market Restraint Impact
  • Fig. 17 Human Papilloma Virus (HPV) Testing Market Strategic Initiatives Analysis
  • Fig. 18 Human Papilloma Virus (HPV) Testing Market: Application Movement Analysis
  • Fig. 19 Human Papilloma Virus (HPV) Testing Market: Application Outlook and Key Takeaways
  • Fig. 20 Cervical Cancer Screening Market Estimates and Forecast, 2018 - 2030
  • Fig. 21 Vaginal Cancer Screening Market Estimates and Forecast, 2018 - 2030
  • Fig. 22 Human Papilloma Virus (HPV) Testing Market: Product Movement Analysis
  • Fig. 23 Human Papilloma Virus (HPV) Testing Market: Product Outlook and Key Takeaways
  • Fig. 24 Instruments Market Estimates and Forecast, 2018 - 2030
  • Fig. 25 Consumables Market Estimates and Forecast, 2018 - 2030
  • Fig. 26 Services Market Estimates and Forecast, 2018 - 2030
  • Fig. 27 Human Papilloma Virus (HPV) Testing Market: Technology Movement Analysis
  • Fig. 28 Human Papilloma Virus (HPV) Testing Market: Technology Outlook and Key Takeaways
  • Fig. 29 PCR Market, 2018 - 2030 (USD Million)
  • Fig. 30 Immunodiagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 31 Others Market, 2018 - 2030 (USD Million)
  • Fig. 32 Human Papilloma Virus (HPV) Testing Market: End Use Movement Analysis
  • Fig. 33 Human Papilloma Virus (HPV) Testing Market: End Use Outlook and Key Takeaways
  • Fig. 34 Hospitals & Clinics Market, 2018 - 2030 (USD Million)
  • Fig. 35 Laboratories Market, 2018 - 2030 (USD Million)
  • Fig. 36 Others Market, 2018 - 2030 (USD Million)
  • Fig. 37 Global Human Papilloma Virus (HPV) Testing Market: Regional Movement Analysis
  • Fig. 38 Global Human Papilloma Virus (HPV) Testing Market: Regional Outlook and Key Takeaways
  • Fig. 39 North America Market Estimates and Forecasts, 2018 - 2030
  • Fig. 40 U.S. Market Estimates and Forecasts, 2018 - 2030
  • Fig. 41 Canada Market Estimates and Forecasts, 2018 - 2030
  • Fig. 42 Mexico Market Estimates and Forecasts, 2018 - 2030
  • Fig. 43 Europe Market Estimates and Forecasts, 2018 - 2030
  • Fig. 44 Germany Market Estimates and Forecasts, 2018 - 2030
  • Fig. 45 U.K. Market Estimates and Forecasts, 2018 - 2030
  • Fig. 46 France Market Estimates and Forecasts, 2018 - 2030
  • Fig. 47 Italy Market Estimates and Forecasts, 2018 - 2030
  • Fig. 48 Spain Market Estimates and Forecasts, 2018 - 2030
  • Fig. 49 Denmark Market Estimates and Forecasts, 2018 - 2030
  • Fig. 50 Sweden Market Estimates and Forecasts, 2018 - 2030
  • Fig. 51 Norway Market Estimates and Forecasts, 2018 - 2030
  • Fig. 52 Asia Pacific Market Estimates and Forecasts, 2018 - 2030
  • Fig. 53 Japan Market Estimates and Forecasts, 2018 - 2030
  • Fig. 54 China Market Estimates and Forecasts, 2018 - 2030
  • Fig. 55 India Market Estimates and Forecasts, 2018 - 2030
  • Fig. 56 South Korea Market Estimates and Forecasts, 2018 - 2030
  • Fig. 57 Australia Market Estimates and Forecasts, 2018 - 2030
  • Fig. 58 Thailand Market Estimates and Forecasts, 2018 - 2030
  • Fig. 59 Latin America Market Estimates and Forecasts, 2018 - 2030
  • Fig. 60 Brazil Market Estimates and Forecasts, 2018 - 2030
  • Fig. 61 Argentina Market Estimates and Forecasts, 2018 - 2030
  • Fig. 62 Middle East & Africa Market Estimates and Forecasts, 2018 - 2030
  • Fig. 63 South Africa Market Estimates and Forecasts, 2018 - 2030
  • Fig. 64 Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
  • Fig. 65 UAE Market Estimates and Forecasts, 2018 - 2030
  • Fig. 66 Kuwait Market Estimates and Forecasts, 2018 - 2030